TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05878314 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05878314 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05877105 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06195605 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04915300 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study NCT04915300 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT05598528 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05598528 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05512390 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05276453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05673850 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05673850 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06121544 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05730673 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT05269550 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06630442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05625750 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05076929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06341283 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06341283 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05415787 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05415787 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04890613 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04890613 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04890613 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT04873869 — Predictive Biomarker (PRD): SCN8A mRNA
Genes: SCN8A; MED
Study NCT06272656 — Predictive Biomarker (PRD): AKR1B10 mRNA
Genes: AKR1B10; AKR1B11
Study NCT06272656 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05045703 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT05045703 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT05426668 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05588141 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05588141 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04717076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04731116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04731116 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05583357 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05953350 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05953350 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06050993 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06050993 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT05916248 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04772235 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04984408 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04954235 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04934072 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04934072 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT06466265 — Predictive Biomarker (PRD): CEACAM6 mRNA
Genes: CEACAM6; NCA
Study NCT05955833 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05025371 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05025371 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT06575959 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05713370 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04100187 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06494813 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06494813 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06494813 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06494813 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06494813 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT06072859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04839991 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06309758 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05781763 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05781763 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT05781763 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05781763 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05781763 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05781763 — Safety Biomarker (SAF): Interleukin 1
Study NCT05781763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05781763 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT04359459 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05161936 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT06495281 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00011284 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05898373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05011032 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06369181 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT06369181 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06369181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06369181 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06369181 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06369181 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05919056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06235541 — Predictive Biomarker (PRD): CNTN4 mRNA
Genes: CNTN4
Study NCT06364956 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06147154 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT06147154 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06398639 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06607484 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06607484 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06704633 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06281405 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05756907 — Predictive Biomarker (PRD): SON mRNA
Genes: SON; C21orf50; DBP5; KIAA1019; NREBP; HSPC310; HSPC312
Study NCT06707519 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06707519 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06713135 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05962372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06714669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05928676 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05523739 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06248697 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT06248697 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06713174 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06713174 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04795362 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06311110 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT05372939 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05189197 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05189197 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT05189197 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05598489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05598489 — Safety Biomarker (SAF): Bacteroidetes phylum
Study NCT06431178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04591210 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04591210 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06155240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05488353 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05141747 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06387225 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06367114 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01604200 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04055389 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT04844346 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04844346 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00009555 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05448131 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT05448131 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06440759 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06440759 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06137053 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT05742750 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05030701 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT03939832 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05735496 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05735496 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05196035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05196035 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05196035 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05121909 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06354088 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04856618 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05371197 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06500715 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05016050 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05796973 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT05557669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05348915 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04730375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06431958 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study NCT06431958 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT06431958 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT06025383 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT06025383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04469803 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05381168 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05039385 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05845593 — Predictive Biomarker (PRD): RNPC3 mRNA
Genes: RNPC3; KIAA1839; RBM40; RNP; SNRNP65
Study NCT05845593 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06093503 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06093503 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05926193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06473428 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06051825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04794946 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06308445 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05023655 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT05753475 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05520177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05520177 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05037669 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05037669 — Predictive Biomarker (PRD): CIITA mRNA
Genes: CIITA; MHC2TA
Study NCT05037669 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04764253 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06251427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05593640 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT04775134 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05214235 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05916287 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study NCT04941911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05967403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05932680 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05796882 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05796882 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000853 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00000853 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT00000853 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT00000853 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00000853 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06470464 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06419309 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06419309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06419309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06419309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05154929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03724227 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06241482 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04249648 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04201210 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04201210 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04797728 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04797728 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04797728 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05537857 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04944550 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05280158 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04956965 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05099406 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05596786 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06107673 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05210946 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00002390 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05757700 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05597917 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT06128226 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT06286046 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT06286046 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06361810 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06361810 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06361810 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05825196 — Predictive Biomarker (PRD): FAM3C mRNA
Genes: FAM3C; ILEI; GS3786
Study NCT05825196 — Predictive Biomarker (PRD): LAMB1 mRNA
Genes: LAMB1
Study NCT05825196 — Predictive Biomarker (PRD): SDC4 mRNA
Genes: SDC4
Study NCT04938388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06185569 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06185569 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04648241 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06237127 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06545799 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05651516 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00043212 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05348694 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05034354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06358677 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05524909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06553820 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05639205 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04552717 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT06433063 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06194669 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT04922762 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05682469 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04780256 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT05687565 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05435742 — Predictive Biomarker (PRD): SON mRNA
Genes: SON; C21orf50; DBP5; KIAA1019; NREBP; HSPC310; HSPC312
Study NCT04771871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04771871 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05016752 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05016752 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05507892 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04011748 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05038371 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05038371 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT05038371 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06482424 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04858529 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04858529 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04858529 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05395780 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT05667493 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06029998 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05456893 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT06155214 — Predictive Biomarker (PRD): KCNIP3 mRNA
Genes: KCNIP3; CSEN; DREAM; KCHIP3
Study NCT06132750 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study NCT06132750 — Predictive Biomarker (PRD): SELENON mRNA
Genes: SELENON; SELN; SEPN1
Study NCT06535321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05075629 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05238103 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05238103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05238103 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06119412 — Surrogate Endpoint (SUR): Blood pressure